Interestingly, we detected an association between patient survival and gene expression of USP9X only, but not of HUWE1, BTRC, and FBXW7, even though all gene products are able to interact with Mcl-1, further emphasizing the role of the deubiquitinase in prostate cancer progression. This evidence concerns the gene BTRC and prostate carcinoma.